Key Points Takeover speculation is rife in the industry, particularly with companies with promising obesity drug pipelines. Management reassured investors that there could be substantial value in its lead drug candidate, VK2735. 10 stocks we like better than Viking Therapeutics › Shares in Viking Therapeutics (NASDAQ: VKTX) rose by a whopping 44.9% in October, according to data provided by S&P Global Market Intelligence. The move occurred in three legs, and each one was preceded by positive news fl ...